1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6E97EDEE41CC73F85852580880072AB67
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-developing-strong-field-based-medical-teams-staffing-salaries-headcount-training?opendocument
18
19opendocument
2018.204.227.250
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Medical Science Liaison

Developing Strong Field-Based Medical Teams: Staffing Salaries, Headcount and Training

ID: 5444


Features:

11 Info Graphics

28 Data Graphics

400+ Metrics

2 Narratives


Pages/Slides: 49


Published: 2016


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Developing Strong Field-Based Medical Teams: Staffing Salaries, Headcount and Training"

STUDY OVERVIEW

Effective field-based medical teams can make a big difference when it comes to a pharmaceutical company's performance. The two primary functions on field-based medical teams are Medical Science Liaisons (MSLs) and Health Outcomes Liaisons (HOLs), with MSLs primarily responsible for providers and HOLs responsible for payers.

With pharma companies relying on MSLs and HOLs to educate key external stakeholders about their company's products and pipelines, it's vital that organizations have the appropriate salaries, headcounts and training for these two field functions. Best Practices, LLC conducted a research project to provide leaders of field-based medical teams with current metrics on salary and staffing levels for MSLs and HOLs. The study also provides metrics on training topics and amounts for these two functions.
This study provides segment perspectives on large and small companies as well as global vs. U.S.-only companies.


KEY TOPICS

  • Field-Based Medical Team Salaries
  • Span of Control and Headcount
  • Reasons of Change in FBMT Headcount
  • Planning Field-Based Medical Team Training
  • Duration of Training

SAMPLE KEY METRICS
  • Annual base salaries for MSL directors, managers, and MSLs in your organization
  • Annual base salaries for HOL directors, managers, and HOLs in your organization
  • Types of field-based medical team members in your organization
  • Number of FTEs in your organization for MSL directors, managers and MSLs
  • Number of FTEs in your organization for HOL directors, managers and HOLs
  • Span of control metrics for the MSL function
  • Key factors for increasing MSL headcount
  • Key factors for increasing HOL headcount
  • Key factors for decreasing MSL headcount
  • Key factors for decreasing HOL headcount
  • Presence of standardized training for seven key topics
  • Frequency of MSL training for nine key areas
  • Annual amount of MSL training in 9 key areas
  • Annual amount of HOL training in 9 key areas

SAMPLE KEY FINDINGS
  • Training Areas: Training most frequently conducted for field-based medical teams are:

-- New product training
-- Scientific training
  • Standardized Training: While majority of the participants use standardized training for their field-based medical teams, they prefer to customize certain parts of their training programs. Three top areas for customization are: 1. Scientific information 2. Therapeutic area of focus 3. Compliance. Differences between therapeutic areas and compliance drive a majority of the customization efforts.
METHODOLOGY

Best Practices, LLC engaged 23 leaders from 19 biopharmaceutical companies through a benchmarking survey.


Industries Profiled:
Pharmaceutical; Biotech; Manufacturing; Consumer Products; Diagnostic; Medical Device; Chemical; Biopharmaceutical; Health Care; Clinical Research; Laboratories


Companies Profiled:
Abbvie; Tocagen; AstraZeneca; Bayer; EMD Serono; Genentech; Incyte; Kyowa Hakko Kirin; Medivation; Merck; Novartis; Pfizer; Pierre Fabre Medicament; Sanofi; Genzyme; Santen; Shire; ViiV Healthcare; ZS Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.